Literature DB >> 21232883

Antimicrobial resistance in fecal Escherichia coli isolated from growing chickens on commercial broiler farms.

Hiroichi Ozaki1, Hidetake Esaki, Kouhei Takemoto, Akira Ikeda, Yasutaka Nakatani, Azusa Someya, Norio Hirayama, Toshiyuki Murase.   

Abstract

To investigate the effects of rearing practices of commercial broiler chickens on the incidence of antimicrobial resistance in commensal Escherichia coli isolates, fecal E. coli isolates obtained in 4 farms were screened for anitimicrobial resistance. Ten E. coli isolates were recovered from each of the fecal samples collected from 10 birds in the farms at the ages of 2 days, 14-17 days, and 47-50 days. In 2 out of the 4 farms, no antimicrobials were used during the rearing period. In the other two farms, following collection of the fecal samples at 14 and 15 days of age, oxytetracycline (OTC), sulfadimethoxine (SDMX), and tylosin were given to birds on one farm and SDMX was used in the other. Isolates resistant to ampicillin and OTC that were obtained from an untreated flock at different sampling times were closely related to each other by pulsed-field gel electrophoresis patterns (PFGE) of XbaI-digested chromosomal DNA. PFGE analysis together with in vitro conjugation experiments suggested that diversity of resistance phenotypes within a clone may be resulted from the acquisition and loss of R-plasmids in an untreated and a treated flock. The numbers of resistance phenotypes observed among fecal isolates increased during the growth of the chickens in all the farms. The results in the present study suggest that persistence of commensal E. coli strains resistant to antimicrobials even in the absence of antimicrobial administration. It is also hypothesized that horizontal transmission of resistance determinants resulted in the emergence of different resistance phenotypes in those farms.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21232883     DOI: 10.1016/j.vetmic.2010.12.020

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  6 in total

1.  High incidence of multidrug resistance and class 1 and 2 integrons in Escherichia coli isolated from broiler chickens in South of Iran.

Authors:  Mohsen Kalantari; Hassan Sharifiyazdi; Keramat Asasi; Bahman Abdi-Hachesoo
Journal:  Vet Res Forum       Date:  2021-03-15       Impact factor: 1.054

2.  Prevalence and risk factors for carriage of antimicrobial-resistant Escherichia coli on household and small-scale chicken farms in the Mekong Delta of Vietnam.

Authors:  Vinh Trung Nguyen; Juan J Carrique-Mas; Thi Hoa Ngo; Huynh Mai Ho; Thanh Tuyen Ha; James I Campbell; Thi Nhung Nguyen; Ngoc Nhung Hoang; Van Minh Pham; Jaap A Wagenaar; Anita Hardon; Quoc Hieu Thai; Constance Schultsz
Journal:  J Antimicrob Chemother       Date:  2015-03-08       Impact factor: 5.790

3.  CTX-M-type extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolated from cases of bovine mastitis in Japan.

Authors:  Nobukazu Saishu; Hiroichi Ozaki; Toshiyuki Murase
Journal:  J Vet Med Sci       Date:  2014-05-01       Impact factor: 1.267

4.  Resistance of Escherichia coli in Turkeys after Therapeutic or Environmental Exposition with Enrofloxacin Depending on Flooring.

Authors:  Bussarakam Chuppava; Birgit Keller; Amr Abd El-Wahab; Jessica Meißner; Manfred Kietzmann; Christian Visscher
Journal:  Int J Environ Res Public Health       Date:  2018-09-13       Impact factor: 3.390

5.  Antimicrobial resistance in commensal Escherichia coli isolated from animals at slaughter.

Authors:  Dariusz Wasyl; Andrzej Hoszowski; Magdalena Zając; Krzysztof Szulowski
Journal:  Front Microbiol       Date:  2013-08-05       Impact factor: 5.640

6.  Resistance Reservoirs and Multi-Drug Resistance of Commensal Escherichia coli From Excreta and Manure Isolated in Broiler Houses With Different Flooring Designs.

Authors:  Bussarakam Chuppava; Birgit Keller; Amr Abd El-Wahab; Christian Sürie; Christian Visscher
Journal:  Front Microbiol       Date:  2019-11-08       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.